Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

NPS Pharma will have to wait another three months for an FDA OK
Fierce Biotech
Saturday, October 25, 2014 - 9:42am
tags:
NPS Pharmaceuticals, Natpara, hypoparathyroidism, FDA
Biogen Falls on Concerns Regarding Tecfidera Sales and PML Case
Yahoo/Zacks.com
Saturday, October 25, 2014 - 9:37am
tags:
Biogen Idec, earnings, Tecfidera
Allergan 3Q Earnings Preview
Bidness Etc.
Saturday, October 25, 2014 - 9:34am
tags:
Allergan, earnings
Biotech Offerings Fuel Health Care IPO Dominance
Investors.com
Friday, October 24, 2014 - 7:22pm
tags:
biotech, IPOs
Are personalized approaches the solution for a troubled cancer vaccine field?
Fierce Vaccines
Friday, October 24, 2014 - 7:09pm
tags:
personalized medicine, vaccines
Shire’s Got Big Plans for AbbVie’s Breakup Fee
WSJ Online
Friday, October 24, 2014 - 7:05pm
tags:
AbbVie, Shire, M&A, Allergan
What to look for in Pfizer earnings
Marketwatch
Friday, October 24, 2014 - 7:04pm
tags:
Pfizer, earnings
Mead Johnson Rises On Earnings Beat
Bidness Etc.
Friday, October 24, 2014 - 10:54am
tags:
Mead Johnson Nutrition, earnings
Is AstraZeneca Getting Ready to Exit Antibiotics Research?
WSJ Pharmalot
Friday, October 24, 2014 - 10:08am
tags:
AstraZeneca, antibiotics, R&D
FDA clears Baxter hemophilia A treatment
Seeking Alpha
Friday, October 24, 2014 - 9:41am
tags:
Baxter International, FDA, hemophilia A, Obizur
Pfizer Stock Buyback Plan Just Too Large to Ignore — It Is on Viagra
24/7 Wall St
Friday, October 24, 2014 - 8:38am
tags:
Pfizer, stock buyback
High Drug Prices Could Increase Industry Innovation
Forbes
Friday, October 24, 2014 - 8:37am
tags:
innovation, drug pricing
Pfizer stock buyback dims prospects of AstraZeneca bid
Seeking Alpha
Friday, October 24, 2014 - 8:04am
tags:
Pfizer, AstraZeneca, M&A, stock buyback
Actavis CEO Saunders Has $70 Billion in Deals to Choose From
Bloomberg
Friday, October 24, 2014 - 8:02am
tags:
Actavis, M&A, Brent Saunders, Allergan, Pfizer, Omega Pharma, Salix
Bristol-Myers beats 3Q earnings and revenue expectations
Yahoo/AP
Friday, October 24, 2014 - 7:45am
tags:
Bristol-Myers Squibb, earnings
Why Earnings Season Could Be Great for Ligand
Yahoo/Zacks.com
Friday, October 24, 2014 - 7:36am
tags:
earnings, Ligand
Head of GSK Ebola Vaccine Research: "Can We Even Consider Doing A Trial?"
Forbes
Friday, October 24, 2014 - 7:35am
tags:
vaccines, ebola virus, R&D, clinical trials, GSK
Jilted Shire raises guidance again after Q3 earnings jump
Yahoo/Reuters
Friday, October 24, 2014 - 7:32am
tags:
Shire, earnings
AstraZeneca ovarian cancer drug wins European green light
Yahoo/Reuters
Friday, October 24, 2014 - 7:31am
tags:
AstraZeneca, ovarian cancer, Europe, Lynparza, olaparib
In biotech's boardrooms, there are 10 men for every one woman, report says
Fierce Biotech
Thursday, October 23, 2014 - 5:43pm
tags:
biotech

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.